+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cat Medicines Market - Global Forecast 2026-2032- Product Image
Cat Medicines Market - Global Forecast 2026-2032- Product Image
Sale

Cat Medicines Market - Global Forecast 2026-2032

  • Report

  • 181 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6011229
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Cat Medicines Market is projected to reach USD 18.27 Billion in 2026. It is expected to continue growing at a CAGR of 10.74%, reaching USD 33.94 Billion by 2032.

Cat Medicines: Executive Summary

Cat medicines encompass prescription and non-prescription products used to prevent, diagnose, manage, and treat feline conditions. The category includes parasiticides, vaccines, anti-infectives, analgesics, dermatology treatments, gastrointestinal therapies, and medicines for chronic diseases. Demand is shaped by companion-animal ownership, veterinary access, preventive-care practices, product safety, and regulatory requirements. Because cats often conceal symptoms, timely clinical assessment and adherence to veterinary guidance are especially important.

Preventive Care and Feline-Centered Treatment Are Reshaping the Category

The landscape is shifting from episodic treatment toward prevention, early diagnosis, and long-term disease management. Owners increasingly seek products that are easier to administer, reduce stress, and address the distinctive physiology and behavior of cats. Veterinary clinics are also placing greater emphasis on parasite control, vaccination, dental health, weight management, and monitoring of chronic conditions.

Digital ordering, tele-advice, home delivery, and clinic-connected pharmacy services are improving convenience, while regulatory scrutiny continues to focus on efficacy, safety, labeling, counterfeit prevention, and responsible antimicrobial use. These changes favor clear dosing instructions, feline-specific formulations, robust pharmacovigilance, and coordinated support for veterinarians and owners.

Artificial Intelligence Is Strengthening Diagnosis, Adherence, and Product Development

Artificial intelligence is contributing to cat-medicine workflows through clinical decision support, image and laboratory-data interpretation, risk stratification, and automated reminders. Applications can help identify patterns associated with dermatological, renal, metabolic, or infectious conditions, but outputs require veterinary validation and should not replace professional diagnosis.

AI also supports demand forecasting, adverse-event signal detection, customer-service triage, and the design of palatable or easier-to-administer formulations. The most practical near-term value lies in integrating AI with verified clinical records, transparent evidence standards, privacy safeguards, and human oversight. Poor-quality data, species misclassification, explainability limitations, and regulatory uncertainty remain material constraints.

Regional Insights: Access, Regulation, and Care Models Vary Widely

North America combines comparatively developed veterinary infrastructure with strong demand for preventive care, chronic-disease management, and convenient fulfillment. Latin America presents varied access conditions, with urban clinics and retail channels developing alongside affordability constraints and uneven regulatory enforcement. Europe emphasizes product quality, animal welfare, prescription controls, and harmonized regulatory processes, although access differs across countries.

The Middle East is characterized by concentrated veterinary services in major urban centers and rising companion-animal awareness, while affordability and distribution remain important considerations. Africa shows substantial variation in clinic availability, medicine supply, and parasite-control practices, creating a need for dependable distribution and veterinary education. Asia-Pacific contains highly diverse markets, ranging from advanced companion-animal care systems to areas where basic access, cold-chain reliability, and professional coverage remain limited.

Group Insights: Economic and Political Blocs Shape Market Access

ASEAN markets reflect different regulatory systems, income levels, and veterinary capacities, making localized registration, distribution, and education important. BRICS economies combine large and diverse companion-animal populations with varied domestic manufacturing, import, and affordability conditions. The European Union benefits from shared regulatory structures, while national reimbursement, prescribing, and retail practices still influence access.

G7 countries generally have mature veterinary networks, strong consumer awareness, and high expectations for product evidence, convenience, and safety. GCC markets are supported by urbanization and concentrated purchasing power but require attention to import procedures, climate-sensitive logistics, and local veterinary capacity. NATO members span distinct regulatory and economic environments; collaboration in this group is more relevant to resilience, supply continuity, and standards than to a single unified commercial model.

Country Insights: Local Veterinary Systems Determine Adoption Pathways

Australia has a developed veterinary system and strong emphasis on preventive care, while Brazil combines significant urban demand with regional differences in access and affordability. Canada and the United States support broad clinic, retail, and digital-fulfillment channels, with regulation and veterinarian involvement central to product use. China is expanding companion-animal services while navigating evolving regulation and uneven regional access. France, Germany, Italy, Spain, and the United Kingdom place substantial weight on veterinary oversight, product safety, and established clinical channels, with differences in national purchasing and prescribing practices.

India’s opportunity is closely linked to urban veterinary expansion, affordability, and owner education. Japan has a mature pet-care environment and strong expectations for reliability and convenience. Mexico combines growing urban demand with variable clinic coverage and distribution infrastructure. Russia’s access conditions are influenced by domestic supply, import constraints, and regional disparities. South Korea has advanced urban veterinary services and digitally engaged owners, supporting interest in convenient, high-quality feline care.

Actions for Leaders: Build Trust, Access, and Feline-Specific Value

Industry leaders should prioritize evidence-backed feline formulations, palatability, practical administration, and clear safety information. Segment portfolios around prevention, acute treatment, and chronic-care pathways rather than relying on undifferentiated product expansion. Strengthening pharmacovigilance, antimicrobial stewardship, traceability, and counterfeit controls can protect both animals and brand credibility.

Distribution strategies should combine veterinary clinics with compliant digital and retail channels, adapting to local prescription rules and access conditions. Partnerships with clinics, shelters, educators, and professional associations can improve diagnosis and adherence. AI investments should focus on validated use cases, interoperable data, privacy, and human review. Regional execution should account for climate, language, affordability, logistics, and regulatory requirements.

Methodology: Evidence-Led Review of the Cat-Medicines Landscape

This executive summary uses a structured qualitative review of the cat-medicines category, organized around product use, veterinary-care pathways, regulation, distribution, technology, and regional access conditions. Geographic analysis covers North America, Latin America, Europe, the Middle East, Africa, and Asia-Pacific, with additional consideration of ASEAN, BRICS, the European Union, G7, GCC, and NATO groupings.

Country perspectives address Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Russia, South Korea, Spain, the United Kingdom, and the United States. Findings are framed as comparative industry insights rather than market estimates. Interpretation should be validated against current veterinary guidance, national regulatory sources, product labels, and up-to-date clinical evidence before commercial or medical decisions are made.

Conclusion: Responsible Innovation Will Define Competitive Advantage

The cat-medicines landscape is being shaped by preventive care, feline-specific treatment design, expanding veterinary access, digital fulfillment, and stronger expectations for safety and evidence. Regional and country differences mean that successful strategies must balance standardized quality with locally appropriate registration, pricing, logistics, education, and clinical support.

Leaders that combine trusted veterinary relationships, convenient administration, resilient supply chains, responsible AI, and rigorous post-market monitoring will be better positioned to serve changing needs. The central opportunity is not simply to increase product availability, but to improve timely diagnosis, treatment adherence, and sustained feline health through responsible, accessible care.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Cat Medicines Market, by Therapeutic Area
7.1. Introduction
7.2. Anesthetics
7.2.1. General
7.2.2. Local
7.3. Anti-Infectives
7.3.1. Injectable Antibiotics
7.3.2. Oral Antibiotics
7.4. Anti-Inflammatories
7.4.1. NSAIDs
7.4.2. Steroids
7.5. Endocrine
7.5.1. Insulin
7.5.2. Thyroid
7.6. Parasiticides
7.6.1. Injectable
7.6.2. Oral
7.6.3. Topical
7.7. Vaccines
7.7.1. Inactivated
7.7.2. Live
8. Cat Medicines Market, by Product Type
8.1. Introduction
8.2. Injectable Products
8.2.1. Intramuscular
8.2.2. Intravenous
8.2.3. Subcutaneous
8.3. Liquid Dosage Forms
8.3.1. Oral Solutions
8.3.2. Suspensions
8.3.3. Syrups
8.4. Solid Dosage Forms
8.4.1. Capsules
8.4.2. Powders
8.4.3. Tablets
8.5. Topical Products
8.5.1. Ointments
8.5.2. Shampoos
8.5.3. Spot-On Treatments
9. Cat Medicines Market, by Route Of Administration
9.1. Introduction
9.2. Oral
9.2.1. Liquid Oral
9.2.2. Solid Oral
9.3. Parenteral
9.3.1. Intramuscular
9.3.2. Intravenous
9.3.3. Subcutaneous
9.4. Topical
9.4.1. Local Topical
9.4.2. Transdermal
10. Cat Medicines Market, by End User
10.1. Introduction
10.2. Pet Owners
10.3. Veterinary Professionals
10.3.1. Hospital Clinics
10.3.2. Private Practices
11. Cat Medicines Market, by Region
11.1. Introduction
11.2. Asia-Pacific
11.3. North America
11.4. Latin America
11.5. Europe
11.6. Middle East
11.7. Africa
12. Cat Medicines Market, by Group
12.1. Introduction
12.2. ASEAN
12.3. GCC
12.4. European Union
12.5. BRICS
12.6. G7
12.7. NATO
13. Cat Medicines Market, by Country
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. United Kingdom
13.7. Germany
13.8. France
13.9. Russia
13.10. Italy
13.11. Spain
13.12. China
13.13. India
13.14. Japan
13.15. Australia
13.16. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. Market Concentration Analysis, 2025
14.2.1. Concentration Ratio (CR)
14.2.2. Herfindahl Hirschman Index (HHI)
14.3. Recent Developments & Impact Analysis, 2025
14.4. Product Portfolio Analysis, 2025
14.5. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Bimeda, Inc.
15.2. Boehringer Ingelheim International GmbH
15.3. Ceva Santé Animale S.A.
15.4. Dechra Pharmaceuticals PLC
15.5. Elanco Animal Health Incorporated
15.6. Heska Corporation
15.7. Hester Biosciences Ltd.
15.8. IDEXX Laboratories Inc.
15.9. Merck & Co., Inc.
15.10. Phibro Animal Health Corporation
15.11. Vetoquinol S.A.
15.12. Virbac S.A.
15.13. Zoetis Inc.
16. Key Experts
LIST OF FIGURES
FIGURE 1. Global Cat Medicines Market, Years Considered for the Study
FIGURE 2. Global Cat Medicines Market, Research Design
FIGURE 3. Global Cat Medicines Market, Research Framework
FIGURE 4. Global Cat Medicines Market, Data Triangulation
FIGURE 5. Global Cat Medicines Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Cat Medicines Market Size, by Therapeutic Area, 2025 vs 2032 (%)
FIGURE 7. Global Cat Medicines Market Size, by Therapeutic Area, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Cat Medicines Market Size, by Product Type, 2025 vs 2032 (%)
FIGURE 9. Global Cat Medicines Market Size, by Product Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Cat Medicines Market Size, by Route Of Administration, 2025 vs 2032 (%)
FIGURE 11. Global Cat Medicines Market Size, by Route Of Administration, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Cat Medicines Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Cat Medicines Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Cat Medicines Market Size, by Region, 2025 vs 2032 (%)
FIGURE 15. Global Cat Medicines Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Cat Medicines Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 17. Global Cat Medicines Market Size, by Country, 2025 vs 2032 (%)
FIGURE 18. Global Cat Medicines Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Cat Medicines Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Cat Medicines Market Segmentation & Coverage
TABLE 2. Global Cat Medicines Market Size, 2017-2032 (USD Million)
TABLE 3. Global Cat Medicines Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 4. Global Anesthetics Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Anesthetics Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Anesthetics Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global General Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global General Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global General Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Local Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Local Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Local Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Anti-Infectives Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Anti-Infectives Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Anti-Infectives Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Injectable Antibiotics Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Injectable Antibiotics Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Injectable Antibiotics Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Oral Antibiotics Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Oral Antibiotics Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Oral Antibiotics Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Anti-Inflammatories Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Anti-Inflammatories Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Anti-Inflammatories Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global NSAIDs Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global NSAIDs Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global NSAIDs Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Steroids Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Steroids Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Steroids Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global Endocrine Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global Endocrine Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global Endocrine Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Insulin Market Size, by Region, 2017-2032 (USD Million)
TABLE 35. Global Insulin Market Size, by Group, 2017-2032 (USD Million)
TABLE 36. Global Insulin Market Size, by Country, 2017-2032 (USD Million)
TABLE 37. Global Thyroid Market Size, by Region, 2017-2032 (USD Million)
TABLE 38. Global Thyroid Market Size, by Group, 2017-2032 (USD Million)
TABLE 39. Global Thyroid Market Size, by Country, 2017-2032 (USD Million)
TABLE 40. Global Parasiticides Market Size, by Region, 2017-2032 (USD Million)
TABLE 41. Global Parasiticides Market Size, by Group, 2017-2032 (USD Million)
TABLE 42. Global Parasiticides Market Size, by Country, 2017-2032 (USD Million)
TABLE 43. Global Injectable Market Size, by Region, 2017-2032 (USD Million)
TABLE 44. Global Injectable Market Size, by Group, 2017-2032 (USD Million)
TABLE 45. Global Injectable Market Size, by Country, 2017-2032 (USD Million)
TABLE 46. Global Oral Market Size, by Region, 2017-2032 (USD Million)
TABLE 47. Global Oral Market Size, by Group, 2017-2032 (USD Million)
TABLE 48. Global Oral Market Size, by Country, 2017-2032 (USD Million)
TABLE 49. Global Topical Market Size, by Region, 2017-2032 (USD Million)
TABLE 50. Global Topical Market Size, by Group, 2017-2032 (USD Million)
TABLE 51. Global Topical Market Size, by Country, 2017-2032 (USD Million)
TABLE 52. Global Vaccines Market Size, by Region, 2017-2032 (USD Million)
TABLE 53. Global Vaccines Market Size, by Group, 2017-2032 (USD Million)
TABLE 54. Global Vaccines Market Size, by Country, 2017-2032 (USD Million)
TABLE 55. Global Inactivated Market Size, by Region, 2017-2032 (USD Million)
TABLE 56. Global Inactivated Market Size, by Group, 2017-2032 (USD Million)
TABLE 57. Global Inactivated Market Size, by Country, 2017-2032 (USD Million)
TABLE 58. Global Live Market Size, by Region, 2017-2032 (USD Million)
TABLE 59. Global Live Market Size, by Group, 2017-2032 (USD Million)
TABLE 60. Global Live Market Size, by Country, 2017-2032 (USD Million)
TABLE 61. Global Cat Medicines Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 62. Global Injectable Products Market Size, by Region, 2017-2032 (USD Million)
TABLE 63. Global Injectable Products Market Size, by Group, 2017-2032 (USD Million)
TABLE 64. Global Injectable Products Market Size, by Country, 2017-2032 (USD Million)
TABLE 65. Global Intramuscular Market Size, by Region, 2017-2032 (USD Million)
TABLE 66. Global Intramuscular Market Size, by Group, 2017-2032 (USD Million)
TABLE 67. Global Intramuscular Market Size, by Country, 2017-2032 (USD Million)
TABLE 68. Global Intravenous Market Size, by Region, 2017-2032 (USD Million)
TABLE 69. Global Intravenous Market Size, by Group, 2017-2032 (USD Million)
TABLE 70. Global Intravenous Market Size, by Country, 2017-2032 (USD Million)
TABLE 71. Global Subcutaneous Market Size, by Region, 2017-2032 (USD Million)
TABLE 72. Global Subcutaneous Market Size, by Group, 2017-2032 (USD Million)
TABLE 73. Global Subcutaneous Market Size, by Country, 2017-2032 (USD Million)
TABLE 74. Global Liquid Dosage Forms Market Size, by Region, 2017-2032 (USD Million)
TABLE 75. Global Liquid Dosage Forms Market Size, by Group, 2017-2032 (USD Million)
TABLE 76. Global Liquid Dosage Forms Market Size, by Country, 2017-2032 (USD Million)
TABLE 77. Global Oral Solutions Market Size, by Region, 2017-2032 (USD Million)
TABLE 78. Global Oral Solutions Market Size, by Group, 2017-2032 (USD Million)
TABLE 79. Global Oral Solutions Market Size, by Country, 2017-2032 (USD Million)
TABLE 80. Global Suspensions Market Size, by Region, 2017-2032 (USD Million)
TABLE 81. Global Suspensions Market Size, by Group, 2017-2032 (USD Million)
TABLE 82. Global Suspensions Market Size, by Country, 2017-2032 (USD Million)
TABLE 83. Global Syrups Market Size, by Region, 2017-2032 (USD Million)
TABLE 84. Global Syrups Market Size, by Group, 2017-2032 (USD Million)
TABLE 85. Global Syrups Market Size, by Country, 2017-2032 (USD Million)
TABLE 86. Global Solid Dosage Forms Market Size, by Region, 2017-2032 (USD Million)
TABLE 87. Global Solid Dosage Forms Market Size, by Group, 2017-2032 (USD Million)
TABLE 88. Global Solid Dosage Forms Market Size, by Country, 2017-2032 (USD Million)
TABLE 89. Global Capsules Market Size, by Region, 2017-2032 (USD Million)
TABLE 90. Global Capsules Market Size, by Group, 2017-2032 (USD Million)
TABLE 91. Global Capsules Market Size, by Country, 2017-2032 (USD Million)
TABLE 92. Global Powders Market Size, by Region, 2017-2032 (USD Million)
TABLE 93. Global Powders Market Size, by Group, 2017-2032 (USD Million)
TABLE 94. Global Powders Market Size, by Country, 2017-2032 (USD Million)
TABLE 95. Global Tablets Market Size, by Region, 2017-2032 (USD Million)
TABLE 96. Global Tablets Market Size, by Group, 2017-2032 (USD Million)
TABLE 97. Global Tablets Market Size, by Country, 2017-2032 (USD Million)
TABLE 98. Global Topical Products Market Size, by Region, 2017-2032 (USD Million)
TABLE 99. Global Topical Products Market Size, by Group, 2017-2032 (USD Million)
TABLE 100. Global Topical Products Market Size, by Country, 2017-2032 (USD Million)
TABLE 101. Global Ointments Market Size, by Region, 2017-2032 (USD Million)
TABLE 102. Global Ointments Market Size, by Group, 2017-2032 (USD Million)
TABLE 103. Global Ointments Market Size, by Country, 2017-2032 (USD Million)
TABLE 104. Global Shampoos Market Size, by Region, 2017-2032 (USD Million)
TABLE 105. Global Shampoos Market Size, by Group, 2017-2032 (USD Million)
TABLE 106. Global Shampoos Market Size, by Country, 2017-2032 (USD Million)
TABLE 107. Global Spot-On Treatments Market Size, by Region, 2017-2032 (USD Million)
TABLE 108. Global Spot-On Treatments Market Size, by Group, 2017-2032 (USD Million)
TABLE 109. Global Spot-On Treatments Market Size, by Country, 2017-2032 (USD Million)
TABLE 110. Global Cat Medicines Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 111. Global Oral Market Size, by Region, 2017-2032 (USD Million)
TABLE 112. Global Oral Market Size, by Group, 2017-2032 (USD Million)
TABLE 113. Global Oral Market Size, by Country, 2017-2032 (USD Million)
TABLE 114. Global Liquid Oral Market Size, by Region, 2017-2032 (USD Million)
TABLE 115. Global Liquid Oral Market Size, by Group, 2017-2032 (USD Million)
TABLE 116. Global Liquid Oral Market Size, by Country, 2017-2032 (USD Million)
TABLE 117. Global Solid Oral Market Size, by Region, 2017-2032 (USD Million)
TABLE 118. Global Solid Oral Market Size, by Group, 2017-2032 (USD Million)
TABLE 119. Global Solid Oral Market Size, by Country, 2017-2032 (USD Million)
TABLE 120. Global Parenteral Market Size, by Region, 2017-2032 (USD Million)
TABLE 121. Global Parenteral Market Size, by Group, 2017-2032 (USD Million)
TABLE 122. Global Parenteral Market Size, by Country, 2017-2032 (USD Million)
TABLE 123. Global Intramuscular Market Size, by Region, 2017-2032 (USD Million)
TABLE 124. Global Intramuscular Market Size, by Group, 2017-2032 (USD Million)
TABLE 125. Global Intramuscular Market Size, by Country, 2017-2032 (USD Million)
TABLE 126. Global Intravenous Market Size, by Region, 2017-2032 (USD Million)
TABLE 127. Global Intravenous Market Size, by Group, 2017-2032 (USD Million)
TABLE 128. Global Intravenous Market Size, by Country, 2017-2032 (USD Million)
TABLE 129. Global Subcutaneous Market Size, by Region, 2017-2032 (USD Million)
TABLE 130. Global Subcutaneous Market Size, by Group, 2017-2032 (USD Million)
TABLE 131. Global Subcutaneous Market Size, by Country, 2017-2032 (USD Million)
TABLE 132. Global Topical Market Size, by Region, 2017-2032 (USD Million)
TABLE 133. Global Topical Market Size, by Group, 2017-2032 (USD Million)
TABLE 134. Global Topical Market Size, by Country, 2017-2032 (USD Million)
TABLE 135. Global Local Topical Market Size, by Region, 2017-2032 (USD Million)
TABLE 136. Global Local Topical Market Size, by Group, 2017-2032 (USD Million)
TABLE 137. Global Local Topical Market Size, by Country, 2017-2032 (USD Million)
TABLE 138. Global Transdermal Market Size, by Region, 2017-2032 (USD Million)
TABLE 139. Global Transdermal Market Size, by Group, 2017-2032 (USD Million)
TABLE 140. Global Transdermal Market Size, by Country, 2017-2032 (USD Million)
TABLE 141. Global Cat Medicines Market Size, by End User, 2017-2032 (USD Million)
TABLE 142. Global Pet Owners Market Size, by Region, 2017-2032 (USD Million)
TABLE 143. Global Pet Owners Market Size, by Group, 2017-2032 (USD Million)
TABLE 144. Global Pet Owners Market Size, by Country, 2017-2032 (USD Million)
TABLE 145. Global Veterinary Professionals Market Size, by Region, 2017-2032 (USD Million)
TABLE 146. Global Veterinary Professionals Market Size, by Group, 2017-2032 (USD Million)
TABLE 147. Global Veterinary Professionals Market Size, by Country, 2017-2032 (USD Million)
TABLE 148. Global Hospital Clinics Market Size, by Region, 2017-2032 (USD Million)
TABLE 149. Global Hospital Clinics Market Size, by Group, 2017-2032 (USD Million)
TABLE 150. Global Hospital Clinics Market Size, by Country, 2017-2032 (USD Million)
TABLE 151. Global Private Practices Market Size, by Region, 2017-2032 (USD Million)
TABLE 152. Global Private Practices Market Size, by Group, 2017-2032 (USD Million)
TABLE 153. Global Private Practices Market Size, by Country, 2017-2032 (USD Million)
TABLE 154. Global Cat Medicines Market Size, by Region, 2017-2032 (USD Million)
TABLE 155. Asia-Pacific Cat Medicines Market Size, by Region, 2017-2032 (USD Million)
TABLE 156. Asia-Pacific Cat Medicines Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 157. Asia-Pacific Cat Medicines Market Size, by Anesthetics, 2017-2032 (USD Million)
TABLE 158. Asia-Pacific Cat Medicines Market Size, by Anti-Infectives, 2017-2032 (USD Million)
TABLE 159. Asia-Pacific Cat Medicines Market Size, by Anti-Inflammatories, 2017-2032 (USD Million)
TABLE 160. Asia-Pacific Cat Medicines Market Size, by Endocrine, 2017-2032 (USD Million)
TABLE 161. Asia-Pacific Cat Medicines Market Size, by Parasiticides, 2017-2032 (USD Million)
TABLE 162. Asia-Pacific Cat Medicines Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 163. Asia-Pacific Cat Medicines Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 164. Asia-Pacific Cat Medicines Market Size, by Injectable Products, 2017-2032 (USD Million)
TABLE 165. Asia-Pacific Cat Medicines Market Size, by Liquid Dosage Forms, 2017-2032 (USD Million)
TABLE 166. Asia-Pacific Cat Medicines Market Size, by Solid Dosage Forms, 2017-2032 (USD Million)
TABLE 167. Asia-Pacific Cat Medicines Market Size, by Topical Products, 2017-2032 (USD Million)
TABLE 168. Asia-Pacific Cat Medicines Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 169. Asia-Pacific Cat Medicines Market Size, by Oral, 2017-2032 (USD Million)
TABLE 170. Asia-Pacific Cat Medicines Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 171. Asia-Pacific Cat Medicines Market Size, by Topical, 2017-2032 (USD Million)
TABLE 172. Asia-Pacific Cat Medicines Market Size, by End User, 2017-2032 (USD Million)
TABLE 173. Asia-Pacific Cat Medicines Market Size, by Veterinary Professionals, 2017-2032 (USD Million)
TABLE 174. North America Cat Medicines Market Size, by Region, 2017-2032 (USD Million)
TABLE 175. North America Cat Medicines Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 176. North America Cat Medicines Market Size, by Anesthetics, 2017-2032 (USD Million)
TABLE 177. North America Cat Medicines Market Size, by Anti-Infectives, 2017-2032 (USD Million)
TABLE 178. North America Cat Medicines Market Size, by Anti-Inflammatories, 2017-2032 (USD Million)
TABLE 179. North America Cat Medicines Market Size, by Endocrine, 2017-2032 (USD Million)
TABLE 180. North America Cat Medicines Market Size, by Parasiticides, 2017-2032 (USD Million)
TABLE 181. North America Cat Medicines Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 182. North America Cat Medicines Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 183. North America Cat Medicines Market Size, by Injectable Products, 2017-2032 (USD Million)
TABLE 184. North America Cat Medicines Market Size, by Liquid Dosage Forms, 2017-2032 (USD Million)
TABLE 185. North America Cat Medicines Market Size, by Solid Dosage Forms, 2017-2032 (USD Million)
TABLE 186. North America Cat Medicines Market Size, by Topical Products, 2017-2032 (USD Million)
TABLE 187. North America Cat Medicines Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 188. North America Cat Medicines Market Size, by Oral, 2017-2032 (USD Million)
TABLE 189. North America Cat Medicines Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 190. North America Cat Medicines Market Size, by Topical, 2017-2032 (USD Million)
TABLE 191. North America Cat Medicines Market Size, by End User, 2017-2032 (USD Million)
TABLE 192. North America Cat Medicines Market Size, by Veterinary Professionals, 2017-2032 (USD Million)
TABLE 193. Latin America Cat Medicines Market Size, by Region, 2017-2032 (USD Million)
TABLE 194. Latin America Cat Medicines Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 195. Latin America Cat Medicines Market Size, by Anesthetics, 2017-2032 (USD Million)
TABLE 196. Latin America Cat Medicines Market Size, by Anti-Infectives, 2017-2032 (USD Million)
TABLE 197. Latin America Cat Medicines Market Size, by Anti-Inflammatories, 2017-2032 (USD Million)
TABLE 198. Latin America Cat Medicines Market Size, by Endocrine, 2017-2032 (USD Million)
TABLE 199. Latin America Cat Medicines Market Size, by Parasiticides, 2017-2032 (USD Million)
TABLE 200. Latin America Cat Medicines Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 201. Latin America Cat Medicines Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 202. Latin America Cat Medicines Market Size, by Injectable Products, 2017-2032 (USD Million)
TABLE 203. Latin America Cat Medicines Market Size, by Liquid Dosage Forms, 2017-2032 (USD Million)
TABLE 204. Latin America Cat Medicines Market Size, by Solid Dosage Forms, 2017-2032 (USD Million)
TABLE 205. Latin America Cat Medicines Market Size, by Topical Products, 2017-2032 (USD Million)
TABLE 206. Latin America Cat Medicines Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 207. Latin America Cat Medicines Market Size, by Oral, 2017-2032 (USD Million)
TABLE 208. Latin America Cat Medicines Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 209. Latin America Cat Medicines Market Size, by Topical, 2017-2032 (USD Million)
TABLE 210. Latin America Cat Medicines Market Size, by End User, 2017-2032 (USD Million)
TABLE 211. Latin America Cat Medicines Market Size, by Veterinary Professionals, 2017-2032 (USD Million)
TABLE 212. Europe Cat Medicines Market Size, by Region, 2017-2032 (USD Million)
TABLE 213. Europe Cat Medicines Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 214. Europe Cat Medicines Market Size, by Anesthetics, 2017-2032 (USD Million)
TABLE 215. Europe Cat Medicines Market Size, by Anti-Infectives, 2017-2032 (USD Million)
TABLE 216. Europe Cat Medicines Market Size, by Anti-Inflammatories, 2017-2032 (USD Million)
TABLE 217. Europe Cat Medicines Market Size, by Endocrine, 2017-2032 (USD Million)
TABLE 218. Europe Cat Medicines Market Size, by Parasiticides, 2017-2032 (USD Million)
TABLE 219. Europe Cat Medicines Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 220. Europe Cat Medicines Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 221. Europe Cat Medicines Market Size, by Injectable Products, 2017-2032 (USD Million)
TABLE 222. Europe Cat Medicines Market Size, by Liquid Dosage Forms, 2017-2032 (USD Million)
TABLE 223. Europe Cat Medicines Market Size, by Solid Dosage Forms, 2017-2032 (USD Million)
TABLE 224. Europe Cat Medicines Market Size, by Topical Products, 2017-2032 (USD Million)
TABLE 225. Europe Cat Medicines Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 226. Europe Cat Medicines Market Size, by Oral, 2017-2032 (USD Million)
TABLE 227. Europe Cat Medicines Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 228. Europe Cat Medicines Market Size, by Topical, 2017-2032 (USD Million)
TABLE 229. Europe Cat Medicines Market Size, by End User, 2017-2032 (USD Million)
TABLE 230. Europe Cat Medicines Market Size, by Veterinary Professionals, 2017-2032 (USD Million)
TABLE 231. Middle East Cat Medicines Market Size, by Region, 2017-2032 (USD Million)
TABLE 232. Middle East Cat Medicines Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 233. Middle East Cat Medicines Market Size, by Anesthetics, 2017-2032 (USD Million)
TABLE 234. Middle East Cat Medicines Market Size, by Anti-Infectives, 2017-2032 (USD Million)
TABLE 235. Middle East Cat Medicines Market Size, by Anti-Inflammatories, 2017-2032 (USD Million)
TABLE 236. Middle East Cat Medicines Market Size, by Endocrine, 2017-2032 (USD Million)
TABLE 237. Middle East Cat Medicines Market Size, by Parasiticides, 2017-2032 (USD Million)
TABLE 238. Middle East Cat Medicines Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 239. Middle East Cat Medicines Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 240. Middle East Cat Medicines Market Size, by Injectable Products, 2017-2032 (USD Million)
TABLE 241. Middle East Cat Medicines Market Size, by Liquid Dosage Forms, 2017-2032 (USD Million)
TABLE 242. Middle East Cat Medicines Market Size, by Solid Dosage Forms, 2017-2032 (USD Million)
TABLE 243. Middle East Cat Medicines Market Size, by Topical Products, 2017-2032 (USD Million)
TABLE 244. Middle East Cat Medicines Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 245. Middle East Cat Medicines Market Size, by Oral, 2017-2032 (USD Million)
TABLE 246. Middle East Cat Medicines Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 247. Middle East Cat Medicines Market Size, by Topical, 2017-2032 (USD Million)
TABLE 248. Middle East Cat Medicines Market Size, by End User, 2017-2032 (USD Million)
TABLE 249. Middle East Cat Medicines Market Size, by Veterinary Professionals, 2017-2032 (USD Million)
TABLE 250. Africa Cat Medicines Market Size, by Region, 2017-2032 (USD Million)
TABLE 251. Africa Cat Medicines Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 252. Africa Cat Medicines Market Size, by Anesthetics, 2017-2032 (USD Million)
TABLE 253. Africa Cat Medicines Market Size, by Anti-Infectives, 2017-2032 (USD Million)
TABLE 254. Africa Cat Medicines Market Size, by Anti-Inflammatories, 2017-2032 (USD Million)
TABLE 255. Africa Cat Medicines Market Size, by Endocrine, 2017-2032 (USD Million)
TABLE 256. Africa Cat Medicines Market Size, by Parasiticides, 2017-2032 (USD Million)
TABLE 257. Africa Cat Medicines Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 258. Africa Cat Medicines Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 259. Africa Cat Medicines Market Size, by Injectable Products, 2017-2032 (USD Million)
TABLE 260. Africa Cat Medicines Market Size, by Liquid Dosage Forms, 2017-2032 (USD Million)
TABLE 261. Africa Cat Medicines Market Size, by Solid Dosage Forms, 2017-2032 (USD Million)
TABLE 262. Africa Cat Medicines Market Size, by Topical Products, 2017-2032 (USD Million)
TABLE 263. Africa Cat Medicines Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 264. Africa Cat Medicines Market Size, by Oral, 2017-2032 (USD Million)
TABLE 265. Africa Cat Medicines Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 266. Africa Cat Medicines Market Size, by Topical, 2017-2032 (USD Million)
TABLE 267. Africa Cat Medicines Market Size, by End User, 2017-2032 (USD Million)
TABLE 268. Africa Cat Medicines Market Size, by Veterinary Professionals, 2017-2032 (USD Million)
TABLE 269. Global Cat Medicines Market Size, by Group, 2017-2032 (USD Million)
TABLE 270. ASEAN Cat Medicines Market Size, by Group, 2017-2032 (USD Million)
TABLE 271. ASEAN Cat Medicines Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 272. ASEAN Cat Medicines Market Size, by Anesthetics, 2017-2032 (USD Million)
TABLE 273. ASEAN Cat Medicines Market Size, by Anti-Infectives, 2017-2032 (USD Million)
TABLE 274. ASEAN Cat Medicines Market Size, by Anti-Inflammatories, 2017-2032 (USD Million)
TABLE 275. ASEAN Cat Medicines Market Size, by Endocrine, 2017-2032 (USD Million)
TABLE 276. ASEAN Cat Medicines Market Size, by Parasiticides, 2017-2032 (USD Million)
TABLE 277. ASEAN Cat Medicines Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 278. ASEAN Cat Medicines Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 279. ASEAN Cat Medicines Market Size, by Injectable Products, 2017-2032 (USD Million)
TABLE 280. ASEAN Cat Medicines Market Size, by Liquid Dosage Forms, 2017-2032 (USD Million)
TABLE 281. ASEAN Cat Medicines Market Size, by Solid Dosage Forms, 2017-2032 (USD Million)
TABLE 282. ASEAN Cat Medicines Market Size, by Topical Products, 2017-2032 (USD Million)
TABLE 283. ASEAN Cat Medicines Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 284. ASEAN Cat Medicines Market Size, by Oral, 2017-2032 (USD Million)
TABLE 285. ASEAN Cat Medicines Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 286. ASEAN Cat Medicines Market Size, by Topical, 2017-2032 (USD Million)
TABLE 287. ASEAN Cat Medicines Market Size, by End User, 2017-2032 (USD Million)
TABLE 288. ASEAN Cat Medicines Market Size, by Veterinary Professionals, 2017-2032 (USD Million)
TABLE 289. GCC Cat Medicines Market Size, by Group, 2017-2032 (USD Million)
TABLE 290. GCC Cat Medicines Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 291. GCC Cat Medicines Market Size, by Anesthetics, 2017-2032 (USD Million)
TABLE 292. GCC Cat Medicines Market Size, by Anti-Infectives, 2017-2032 (USD Million)
TABLE 293. GCC Cat Medicines Market Size, by Anti-Inflammatories, 2017-2032 (USD Million)
TABLE 294. GCC Cat Medicines Market Size, by Endocrine, 2017-2032 (USD Million)
TABLE 295. GCC Cat Medicines Market Size, by Parasiticides, 2017-2032 (USD Million)
TABLE 296. GCC Cat Medicines Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 297. GCC Cat Medicines Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 298. GCC Cat Medicines Market Size, by Injectable Products, 2017-2032 (USD Million)
TABLE 299. GCC Cat Medicines Market Size, by Liquid Dosage Forms, 2017-2032 (USD Million)
TABLE 300. GCC Cat Medicines Market Size, by Solid Dosage Forms, 2017-2032 (USD Million)
TABLE 301. GCC Cat Medicines Market Size, by Topical Products, 2017-2032 (USD Million)
TABLE 302. GCC Cat Medicines Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 303. GCC Cat Medicines Market Size, by Oral, 2017-2032 (USD Million)
TABLE 304. GCC Cat Medicines Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 305. GCC Cat Medicines Market Size, by Topical, 2017-2032 (USD Million)
TABLE 306. GCC Cat Medicines Market Size, by End User, 2017-2032 (USD Million)
TABLE 307. GCC Cat Medicines Market Size, by Veterinary Professionals, 2017-2032 (USD Million)
TABLE 308. European Union Cat Medicines Market Size, by Group, 2017-2032 (USD Million)
TABLE 309. European Union Cat Medicines Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 310. European Union Cat Medicines Market Size, by Anesthetics, 2017-2032 (USD Million)
TABLE 311. European Union Cat Medicines Market Size, by Anti-Infectives, 2017-2032 (USD Million)
TABLE 312. European Union Cat Medicines Market Size, by Anti-Inflammatories, 2017-2032 (USD Million)
TABLE 313. European Union Cat Medicines Market Size, by Endocrine, 2017-2032 (USD Million)
TABLE 314. European Union Cat Medicines Market Size, by Parasiticides, 2017-2032 (USD Million)
TABLE 315. European Union Cat Medicines Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 316. European Union Cat Medicines Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 317. European Union Cat Medicines Market Size, by Injectable Products, 2017-2032 (USD Million)
TABLE 318. European Union Cat Medicines Market Size, by Liquid Dosage Forms, 2017-2032 (USD Million)
TABLE 319. European Union Cat Medicines Market Size, by Solid Dosage Forms, 2017-2032 (USD Million)
TABLE 320. European Union Cat Medicines Market Size, by Topical Products, 2017-2032 (USD Million)
TABLE 321. European Union Cat Medicines Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 322. European Union Cat Medicines Market Size, by Oral, 2017-2032 (USD Million)
TABLE 323. European Union Cat Medicines Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 324. European Union Cat Medicines Market Size, by Topical, 2017-2032 (USD Million)
TABLE 325. European Union Cat Medicines Market Size, by End User, 2017-2032 (USD Million)
TABLE 326. European Union Cat Medicines Market Size, by Veterinary Professionals, 2017-2032 (USD Million)
TABLE 327. BRICS Cat Medicines Market Size, by Group, 2017-2032 (USD Million)
TABLE 328. BRICS Cat Medicines Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 329. BRICS Cat Medicines Market Size, by Anesthetics, 2017-2032 (USD Million)
TABLE 330. BRICS Cat Medicines Market Size, by Anti-Infectives, 2017-2032 (USD Million)
TABLE 331. BRICS Cat Medicines Market Size, by Anti-Inflammatories, 2017-2032 (USD Million)
TABLE 332. BRICS Cat Medicines Market Size, by Endocrine, 2017-2032 (USD Million)
TABLE 333. BRICS Cat Medicines Market Size, by Parasiticides, 2017-2032 (USD Million)
TABLE 334. BRICS Cat Medicines Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 335. BRICS Cat Medicines Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 336. BRICS Cat Medicines Market Size, by Injectable Products, 2017-2032 (USD Million)
TABLE 337. BRICS Cat Medicines Market Size, by Liquid Dosage Forms, 2017-2032 (USD Million)
TABLE 338. BRICS Cat Medicines Market Size, by Solid Dosage Forms, 2017-2032 (USD Million)
TABLE 339. BRICS Cat Medicines Market Size, by Topical Products, 2017-2032 (USD Million)
TABLE 340. BRICS Cat Medicines Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 341. BRICS Cat Medicines Market Size, by Oral, 2017-2032 (USD Million)
TABLE 342. BRICS Cat Medicines Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 343. BRICS Cat Medicines Market Size, by Topical, 2017-2032 (USD Million)
TABLE 344. BRICS Cat Medicines Market Size, by End User, 2017-2032 (USD Million)
TABLE 345. BRICS Cat Medicines Market Size, by Veterinary Professionals, 2017-2032 (USD Million)
TABLE 346. G7 Cat Medicines Market Size, by Group, 2017-2032 (USD Million)
TABLE 347. G7 Cat Medicines Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 348. G7 Cat Medicines Market Size, by Anesthetics, 2017-2032 (USD Million)
TABLE 349. G7 Cat Medicines Market Size, by Anti-Infectives, 2017-2032 (USD Million)
TABLE 350. G7 Cat Medicines Market Size, by Anti-Inflammatories, 2017-2032 (USD Million)
TABLE 351. G7 Cat Medicines Market Size, by Endocrine, 2017-2032 (USD Million)
TABLE 352. G7 Cat Medicines Market Size, by Parasiticides, 2017-2032 (USD Million)
TABLE 353. G7 Cat Medicines Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 354. G7 Cat Medicines Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 355. G7 Cat Medicines Market Size, by Injectable Products, 2017-2032 (USD Million)
TABLE 356. G7 Cat Medicines Market Size, by Liquid Dosage Forms, 2017-2032 (USD Million)
TABLE 357. G7 Cat Medicines Market Size, by Solid Dosage Forms, 2017-2032 (USD Million)
TABLE 358. G7 Cat Medicines Market Size, by Topical Products, 2017-2032 (USD Million)
TABLE 359. G7 Cat Medicines Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 360. G7 Cat Medicines Market Size, by Oral, 2017-2032 (USD Million)
TABLE 361. G7 Cat Medicines Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 362. G7 Cat Medicines Market Size, by Topical, 2017-2032 (USD Million)
TABLE 363. G7 Cat Medicines Market Size, by End User, 2017-2032 (USD Million)
TABLE 364. G7 Cat Medicines Market Size, by Veterinary Professionals, 2017-2032 (USD Million)
TABLE 365. NATO Cat Medicines Market Size, by Group, 2017-2032 (USD Million)
TABLE 366. NATO Cat Medicines Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 367. NATO Cat Medicines Market Size, by Anesthetics, 2017-2032 (USD Million)
TABLE 368. NATO Cat Medicines Market Size, by Anti-Infectives, 2017-2032 (USD Million)
TABLE 369. NATO Cat Medicines Market Size, by Anti-Inflammatories, 2017-2032 (USD Million)
TABLE 370. NATO Cat Medicines Market Size, by Endocrine, 2017-2032 (USD Million)
TABLE 371. NATO Cat Medicines Market Size, by Parasiticides, 2017-2032 (USD Million)
TABLE 372. NATO Cat Medicines Market Size, by Vaccines, 2017-2032 (USD Million)
TABLE 373. NATO Cat Medicines Market Size, by Product Type, 2017-2032 (USD Million)
TABLE 374. NATO Cat Medicines Market Size, by Injectable Products, 2017-2032 (USD Million)
TABLE 375. NATO Cat Medicines Market Size, by Liquid Dosage Forms, 2017-2032 (USD Million)
TABLE 376. NATO Cat Medicines Market Size, by Solid Dosage Forms, 2017-2032 (USD Million)
TABLE 377. NATO Cat Medicines Market Size, by Topical Products, 2017-2032 (USD Million)
TABLE 378. NATO Cat Medicines Market Size, by Route Of Administration, 2017-2032 (USD Million)
TABLE 379. NATO Cat Medicines Market Size, by Oral, 2017-2032 (USD Million)
TABLE 380. NATO Cat Medicines Market Size, by Parenteral, 2017-2032 (USD Million)
TABLE 381. NATO Cat Medicines Market Size, by Topical, 2017-2032 (USD Million)
TABLE 382. NATO Cat Medicines Market Size, by End User, 2017-2032 (USD Million)
TABLE 383. NATO Cat Medicines Market Size, by Veterinary Professionals, 2017-2032 (USD Million)
TABLE 384. Global Cat Medicines Market Size, by Country, 2017-2032 (USD Million)
TABLE 385. United States Cat Medicines Market Size, 2017-2032 (USD Million)
TABLE 386. United States Cat Medicines Market Size, by Therapeutic Area, 2017-2032 (USD Million)
TABLE 387. United States Cat Medicines Market Size, by Anesthetics, 2017-2032 (USD Million)
TA

Companies Mentioned

  • Bimeda, Inc.
  • Boehringer Ingelheim International GmbH
  • Ceva Santé Animale S.A.
  • Dechra Pharmaceuticals PLC
  • Elanco Animal Health Incorporated
  • Heska Corporation
  • Hester Biosciences Ltd.
  • IDEXX Laboratories Inc.
  • Merck & Co., Inc.
  • Phibro Animal Health Corporation
  • Vetoquinol S.A.
  • Virbac S.A.
  • Zoetis Inc.

Related Topics

Related Reports

Veterinary Drug Market - Global Forecast 2026-2032 - Product Image

Veterinary Drug Market - Global Forecast 2026-2032

  • Report
  • 198 Pages
  • Global
From
Veterinary Pain Management Market - Global Forecast 2026-2032 - Product Image

Veterinary Pain Management Market - Global Forecast 2026-2032

  • Report
  • 181 Pages
  • Global
From
Veterinary Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Veterinary Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 180 Pages
  • Global
From
Veterinary Animal Healthcare - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

Veterinary Animal Healthcare - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 180 Pages
  • Global
From
Veterinary Medicine Market Size, Share & Trends Analysis Report by Product, Animal, Route of Administration, Drug Type, Distribution Channel, Region, and Segment Forecasts, 2026-2033 - Product Image

Veterinary Medicine Market Size, Share & Trends Analysis Report by Product, Animal, Route of Administration, Drug Type, Distribution Channel, Region, and Segment Forecasts, 2026-2033

  • Report
  • 150 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.